The wealth of research results in the area of breast cancer diagnosis and therapy with monoclonal antibodies presented in previous workshops is now complemented with a new rendition of the proceedings of the 4th Workshop on Monoclonal Antibodies and Breast Cancer. held in San Francisco on November 5-6. 1990. Basic science findings reported in previous workshops have now percolated to the clinical level and have become immunoassays and imaging and therapy reagents. as the program shows us. Thus. the latest discoveries in immunology. biochemistry and molecular biology of breast epithelial antigens and their corresponding antibodies have produced newer diagnostic tests and therapeutic approaches that are altering and improving the way we attack breast cancer. The recent spectacular and rapid advancements in the molecular biology of several of the breast epithelial antigens are presented in this volume. The way in which the final assembly of different components of the breast antigens is achieved and their functions are now within our grasp as a result of new understanding of molecular structure of these breast antigens. In addition. newer immunoassays aiming at the earliest detection of the disease are also described that integrate with promising attempts at imaging and radioimmunotherapy to set the stage for new oncological possibilities in breast cancer treatment. All these areas of intense involvement of scientists with diverse specialties are presented in this volume. which proves the need for multidisciplinary approaches to increase our chances for success in this field of medical research.

Klappentext

Proceedings of the Fourth International Workshop on Monoclonal Antibodies and Breast Cancer, held in San Francisco, California, November 5-6, 1990.

Inhalt
Session I.- Molecular Analysis of H23 Epithelial Tumor Antigen - Differentially Spliced Full Length cDNAs and Gene.- Characterization and Evolution of an Expressed Hypervariable Gene for Tumor-Associated Mucin, MUC-1.- Structure, Processing, Differential Glycosylation and Biology of Episialin.- Molecular Cloning and Expression of Breast Mucin-Associated Antigens.- Monoclonal Antibodies Reactive with Breast Cancer, Mammary Mucins and Synthetic Peptides.- Molecular Analysis of Epitopic Heterogeneity of the Breast Mucin.- Session II.- Expression and Prognostic Significance of the Her-2/NEU Oncogene During the Evolutionary Progression of Human Breast Cancer.- Structure and Function of MFG-E8: A Novel Apical Membrane Protein of Mouse Mammary Ephelial Cells.- Targeted Lysis of Human Breast Cancer Cells by Human Effector Cells Armed with Bispecific Antibody 2B1 (ANTI-c-erbB-2/ANTI-Fcy Receptor III).- Mechanisms Controlling Steroid Receptor Binding to Specific DNA Sequences.- Session III.- Origin and Nature of the Milk Lipid Globule Membrane.- N-Linked Oligosaccharide Synthesis and Cellular Sociology.- Development of Enzyme Immunoassays for Breast Carcinoma-Associated Mucin Antigens.- Clinical Studies and New Developments with Hybri-BREScan (CA-549), A Monoclonal Assay for Breast Cancer-Associated Antigen.- Evaluation of Several Tumor Markers (MCA, CA 15.3, BCM and CA 549) in Tissue and Serum of Patients with Breast Cancer.- IMx BCM: A Novel Monoclonal Based System for the Detection of Breast Cancer Associated Mucin.- A Novel Serum Assay Using Recombinant Breast Epithelial Mucin Antigen.- Session IV.- RadioimmunoguidedTM Surgery in Breast Cancer.- Immuno-Pharmacologic Purging of Breast Cancer from Bone Marrow.- Imaging, Pharmacokinetics, Dosimetry and Antitumor Effects of Radiolabeled Anti-Breast Cancer Antibodies in Mouse and Man.- Radioimmunotherapy with I-131 Chimeric L-6 in Advanced Breast Cancer.- Contributors.